Medical device recalls Moderate risk

Entopsis , Inc. recalls PCRopsis Reagent RVD with RVD Enhancer: a) 1 mL, VALIDATION USE ONLY, REF 78336001; b) 25 mL, REF 78336025; c) 100 mL,…

Recall date
February 21, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1299-2023
FDA classification
Class II
Brand / firm
Entopsis , Inc.
Sold / distributed
Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania

Why it was recalled

Presence of misleading label statements on the product label.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

PCRopsis Reagent RVD with RVD Enhancer: a) 1 mL, VALIDATION USE ONLY, REF 78336001; b) 25 mL, REF 78336025; c) 100 mL, REF 78336100; Extraction-free PCR from saliva, urine, &swab specimens in transport medium, nucleic acid extraction from a variety of biological samples

Get recall alerts

Free email alert whenever Entopsis , Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Entopsis , Inc.